Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-25 @ 3:57 AM
NCT ID:
NCT06414902
Brief Summary:
To learn if 18F-FAraG PET scans can find tumors in participants with esophageal cancer and predict a participant's response to treatment.
Detailed Description:
Primary Objectives
* Evaluate the ability of 18F-FAraG PET imaging to detect tumors in participants with esophageal cancer;
* Evaluate 18F-FAraG PET as a predictor of pathologic complete response
Secondary Objectives
* Evaluate the correlation of 18F-FAraG PET with clinical characteristics
* Evaluate the correlation of 18F-FAraG PET with scRNA-seq data
* Evaluate tissue and blood biomarkers as predictors of treatment response and disease recurrence
* Evaluate functional imaging with 18F-FAraG PET and tissue and blood biomarkers as predictors of overall survival and disease-free survival
* Compare 18F-FAraG PET SUV update to the change in standard 18FDG-PET SUV parameters before and after chemoradiation.
Study:
NCT06414902
Study Brief:
Protocol Section:
NCT06414902